Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
4519.T - Chugai Pharmaceutical Co Ltd
Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation
Jan 30, 2025 / 09:00AM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
I am a good at the present.
I'll explain the summary of 2024 and the forecast for 2025.
Please take a look at page 4 of the slide.
The full year results of 2024 exceeded the revised forecast for revenue operating profit and income which all with all figures reaching record highs revenue exceeded JPY1 trillion for the third consecutive year and operating profit exceeded JPY500 billion for the first time.
The operating margin also reached a record high of 47.5%.
Regarding domestic sales, the completion of JPY81.2 billion government supply of Ronapreve in 2023 had a significant impact while overseas, especially exports of hemlibra to rush were particularly
